Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yael Lurie, Yona Nadir, Ron Hoffman, Asaf Miller, Edna Efrati, Gil Ring, Dana Sonenfeld, Nitai Bar, Hisam Zaidani, Alexander Strizevsky, Mahdi Asali, Ophir Lavon & Daniel Kurnik. (2023) An outbreak of severe coagulopathy in northern Israel among users of illicit synthetic cannabinoids adulterated with brodifacoum. Clinical Toxicology 61:6, pages 429-435.
Read now
Read now
Jie Li, Yuan Zhang, Yu Zhou & Xue-song Feng. (2022) Cannabinoids: Recent Updates on Public Perception, Adverse Reactions, Pharmacokinetics, Pretreatment Methods and Their Analysis Methods. Critical Reviews in Analytical Chemistry 52:6, pages 1197-1222.
Read now
Read now
Ivo D. Ivanov, Silviya S. Stoykova, Nikola T. Burdzhiev, Ivayla N. Pantcheva & Vasil N. Atanasov. (2021) Synthetic Cannabinoids 5F-QUPIC and MDMB-CHMICA in Plant Material – Identification and Quantification by Gas Chromatography – Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance (NMR), and High-Performance Liquid Chromatography with Diode Array Detection (HPLC-DAD). Analytical Letters 54:16, pages 2600-2610.
Read now
Read now
Hsiangyi Tai, Michael D. Swartz, David Marsden & Cheryl L. Perry. (2021) The Future of Substance Abuse Now: Relationships among Adolescent Use of Vaping Devices, Marijuana, and Synthetic Cannabinoids. Substance Use & Misuse 56:2, pages 192-204.
Read now
Read now
Vera L. Alves, João L. Gonçalves, Joselin Aguiar, Helena M. Teixeira & José S. Câmara. (2020) The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Critical Reviews in Toxicology 50:5, pages 359-382.
Read now
Read now
Tajamul Hussain, Omar S. Al-Attas, Salman A. Alrokayan, Mukhtar Ahmed, Nasser M. Al-Daghri, Salman Al-Ameri, Shamsh Pervez, Shippi Dewangan, Arif Mohammed, Dikshit Gambhir & Terrance S. Sumague. (2016) Deleterious effects of incense smoke exposure on kidney function and architecture in male albino rats. Inhalation Toxicology 28:8, pages 364-373.
Read now
Read now
Robert J. Tait, David Caldicott, David Mountain, Simon L. Hill & Simon Lenton. (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology 54:1, pages 1-13.
Read now
Read now
Articles from other publishers (84)
Anh Tuan Nguyen, Hung Cuong Nguyen, Dang Tien Nguyen, Quoc Cuong Huynh, Minh Hoang Le, Hoang Thuc Huynh & Duy Toan Pham. (2023) Into the synthetic cannabinoid 5-Fluoro-MDMB-PICA in “American grass” illicit drug: Extraction, isolation, structure elucidation, and GC/MS determination. Talanta Open 8, pages 100246.
Crossref
Crossref
Soheir Ali Mohammad, Rasha Elhaddad Ali Mousa, Sahar Mohamed Gebril, Khaled Masoud Mohamed Masoud & Rania Ahmad Radwan. (2023) Toxic effects of AB-CHMINACA on liver and kidney and detection of its blood level in adult male mice. Forensic Toxicology.
Crossref
Crossref
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Crossref
Shivani Sachdev, Marina Santiago & Chris Bladen. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment
383
393
.
Christopher S. Breivogel & Victor M. Pulgar. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment
487
496
.
Gábor Simon, Dénes Tóth, Veronika Heckmann, Mátyás Mayer & Mónika Kuzma. (2022) Simultaneous fatal poisoning of two victims with 4F-MDMB-BINACA and ethanol. Forensic Toxicology 41:1, pages 151-157.
Crossref
Crossref
Lakshmi Kannan. (2022) Renal manifestations of recreational drugs: A narrative review of the literature. Medicine 101:50, pages e31888.
Crossref
Crossref
Eric Sparkes, Rochelle Boyd, Shuli Chen, Jack W. Markham, Jia Lin Luo, Tahira Foyzun, Humayra Zaman, Charlotte Fletcher, Ross Ellison, Iain S. McGregor, Marina J. Santiago, Felcia Lai, Roy R. Gerona, Mark Connor, David E. Hibbs, Elizabeth A. Cairns, Michelle Glass, Adam Ametovski & Samuel D. Banister. (2022) Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs. Frontiers in Psychiatry 13.
Crossref
Crossref
Stefano D’Errico, Martina Zanon, Davide Radaelli, Monica Concato, Martina Padovano, Matteo Scopetti, Paola Frati & Vittorio Fineschi. (2022) Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers. Biomedicines 10:8, pages 1936.
Crossref
Crossref
N. B. Savelieva, G. V. Ishutenko, A. V. Polosin, F. V. Radus, D. S. Polyansky, S. A. Kurbatkin, Yu. A. Efimova & P. V. Postnikov. (2022) Validation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS. Fine Chemical Technologies 17:3, pages 253-267.
Crossref
Crossref
Martin F. Casey & Alex F. Manini. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
415
446
.
Babette Van Rafelghem, Adrian Covaci, Kurt Anseeuw, Alexander L. N. van Nuijs, Hugo Neels, Boris Mahieu & Werner Jacobs. (2021) Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?. Forensic Science, Medicine and Pathology 17:4, pages 684-688.
Crossref
Crossref
Vidyasagar Naik Bukke, Moola Archana, Rosanna Villani, Gaetano Serviddio & Tommaso Cassano. (2021) Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health. Pharmaceuticals 14:10, pages 965.
Crossref
Crossref
Paula Martinez de la Cruz, Amir Shabaka, Xabier Mielgo-Rubio, Carmen Guerrero-Marquez, Sara Gimenez-Moyano & Gema Fernandez-Juarez. (2021) Concomitant Acute Tubular Necrosis and Acute Interstitial Nephritis Induced by Tipifarnib in a Patient with Squamous Cell Carcinoma of the Lung. The American Journal of the Medical Sciences 362:1, pages 99-102.
Crossref
Crossref
Ishtiaq Ahmed, Saif Ur Rehman, Shiva Shahmohamadnejad, Muhammad Anjum Zia, Muhammad Ahmad, Muhammad Muzammal Saeed, Zain Akram, Hafiz M. N. Iqbal & Qingyou Liu. (2021) Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders. Molecules 26:11, pages 3389.
Crossref
Crossref
Selman Yeniocak, Asım Kalkan, Adnan Yamanoğlu, Semi Öztürk, Özgür Söğüt & Merve Metiner. (2021) The effects of synthetic cannabinoids on the cardiovascular system: A case–control study. Turkish Journal of Emergency Medicine 21:4, pages 198.
Crossref
Crossref
Brendan Smyth, Anna Haber & Annemarie Hennessy. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
1113
1132
.
Bruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, Frederic Balen, Sébastien Beaune, Régis Bédry, Anthony Chauvin, Isabelle Claudet, Vincent Danel, Guillaume Debaty, Arnaud Delahaye, Nicolas Deye, Jean-Michel Gaulier, Francis Grossenbacher, Philippe Hantson, Frédéric Jacobs, Karim Jaffal, Magali Labadie, Laurence Labat, Jérôme Langrand, Frédéric Lapostolle, Philippe Le Conte, Maxime Maignan, Patrick Nisse, Philippe Sauder, Christine Tournoud, Dominique Vodovar, Sebastian Voicu, Pierre-Géraud Claret & Charles Cerf. (2020) Management of pharmaceutical and recreational drug poisoning. Annals of Intensive Care 10:1.
Crossref
Crossref
Dennis J. Sholler, Marilyn A. Huestis, Benjamin Amendolara, Ryan Vandrey & Ziva D. Cooper. (2020) Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacology Biochemistry and Behavior 199, pages 173059.
Crossref
Crossref
Sadhana Dharmapuri, Kathleen Miller & Jonathan D. Klein. (2020) Marijuana and the Pediatric Population. Pediatrics 146:2.
Crossref
Crossref
Akihiro Takeda, Takahiro Doi, Akiko Asada, Toshinari Suzuki, Katsuhiro Yuzawa, Hiroshi Ando, Yoshikazu Kubo, Akemichi Nagasawa, Fujifumi Kaihoko, Yuko Hasegawa, Kazuyoshi Tanaka, Kai Igarashi, Tomokazu Maeno, Atsuko Suzuki, Seiko Shimizu, Nozomi Uemura, Jun’ichi Nakajima, Jin Suzuki & Takaomi Tagami. (2020) Evaluation of carboxamide-type synthetic cannabinoids on the functional activities at cannabinoid receptors and biological effects via inhalation exposure test. Forensic Toxicology 38:2, pages 455-464.
Crossref
Crossref
Arianna Giorgetti, Lukas Mogler, Sebastian Halter, Belal Haschimi, Andreas Alt, Daniel Rentsch, Bea Schmidt, Vanessa Thoma, Susanne Vogt & Volker Auwärter. (2019) Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE. Forensic Toxicology 38:2, pages 314-326.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Wen Ma, Shuting Xu, Huwei Liu & Yu Bai. (2020) Mass Spectrometry Methods for In Situ Analysis of Clinical Biomolecules. Small Methods 4:4, pages 1900407.
Crossref
Crossref
Joshua L. Rein. (2020) The nephrologistʼs guide to cannabis and cannabinoids. Current Opinion in Nephrology and Hypertension 29:2, pages 248-257.
Crossref
Crossref
Kassandra R. Fabbri, Tracy L. Anderson‐Haag, Anne M. Spenningsby, Ajay Israni, Rachel M. Nygaard & Paul A. Stahler. (2019) Marijuana use should not preclude consideration for kidney transplantation. Clinical Transplantation 33:10.
Crossref
Crossref
Michael Tatusov, Maryann Mazer-Amirshahi, Aleeza Abbasi & Munish Goyal. (2019) Clinical effects of reported synthetic cannabinoid exposure in patients admitted to the intensive care unit. The American Journal of Emergency Medicine 37:6, pages 1060-1064.
Crossref
Crossref
Eva M. Mathews, Emily Jeffries, Chenen Hsieh, Glenn Jones & Julia D. Buckner. (2019) Synthetic cannabinoid use among college students. Addictive Behaviors 93, pages 219-224.
Crossref
Crossref
Eike Blohm, Peter Sell & Mark Neavyn. (2019) Cannabinoid toxicity in pediatrics. Current Opinion in Pediatrics 31:2, pages 256-261.
Crossref
Crossref
Ivo D. Ivanov, Silviya Stoykova, Elka Ivanova, Aleksandrina Vlahova, Nikola Burdzhiev, Ivayla Pantcheva & Vasil N. Atanasov. (2019) A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?. Forensic Science International 297, pages 372-377.
Crossref
Crossref
Azita Alipour, Puja Baldev Patel, Zaheera Shabbir & Stephen Gabrielson. (2019) Review of the many faces of synthetic cannabinoid toxicities. Mental Health Clinician 9:2, pages 93-99.
Crossref
Crossref
George Sam Wang & Christopher Hoyte. (2019) Novel Drugs of Abuse. Pediatrics In Review 40:2, pages 71-78.
Crossref
Crossref
Claudia Ho, Dan Martinusen & Clifford Lo. (2019) A Review of Cannabis in Chronic Kidney Disease Symptom Management. Canadian Journal of Kidney Health and Disease 6, pages 205435811982839.
Crossref
Crossref
Richard C. Kevin, Alexander L. Kovach, Timothy W. Lefever, Thomas F. Gamage, Jenny L. Wiley, Iain S. McGregor & Brian F. Thomas. (2018) Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic Toxicology 37:1, pages 17-26.
Crossref
Crossref
Paula C. Zimbrean, Jennifer Braverman & Marta Novak. 2019. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Psychosocial Care of End-Stage Organ Disease and Transplant Patients
73
89
.
Libor Uttl, Ewa Szczurowska, Kateřina Hájková, Rachel R. Horsley, Kristýna Štefková, Tomáš Hložek, Klára Šíchová, Marie Balíková, Martin Kuchař, Vincenzo Micale & Tomáš Páleníček. (2018) Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats. Frontiers in Neuroscience 12.
Crossref
Crossref
Lili Zhou, Shan Zhou, Peng Yang, Yuan Tian, Zhiwei Feng, Xiang-Qun Xie & Youhua Liu. (2018) Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis. Kidney International 94:4, pages 756-772.
Crossref
Crossref
Anthea B. Mahesan Paul, Lary Simms, Saeideh Amini & Abraham Ebenezer Paul. (2018) Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use. Journal of Forensic Sciences 63:4, pages 1321-1324.
Crossref
Crossref
Thomas F. Gamage, Charlotte E. Farquhar, Timothy W. Lefever, Julie A. Marusich, Richard C. Kevin, Iain S. McGregor, Jenny L. Wiley & Brian F. Thomas. (2018) Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. Journal of Pharmacology and Experimental Therapeutics 365:2, pages 437-446.
Crossref
Crossref
João P. Silva, Helena Carmo & Félix Carvalho. (2018) The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis. Toxicology Letters 287, pages 59-69.
Crossref
Crossref
Zoltan V. Varga & Pal Pacher. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants
93
110
.
Joshua L. Rein & Christina M. Wyatt. (2018) Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD. American Journal of Kidney Diseases 71:2, pages 267-274.
Crossref
Crossref
Kimberly S. Grant, Rebekah Petroff, Nina Isoherranen, Nephi Stella & Thomas M. Burbacher. (2018) Cannabis use during pregnancy: Pharmacokinetics and effects on child development. Pharmacology & Therapeutics 182, pages 133-151.
Crossref
Crossref
J. Neugarten, B. Friedman & L. Golestaneh. 2018. Comprehensive Toxicology. Comprehensive Toxicology
304
339
.
Samuel D. Banister & Mark Connor. 2018. New Psychoactive Substances. New Psychoactive Substances
191
226
.
Kanaan Mansoor, Murad Kheetan, Saba Shahnawaz, Anna P. Shapiro, Eva Patton-Tackett, Larry Dial, Gary Rankin, Prasanna Santhanam, Antonios H. Tzamaloukas, Tibor Nadasdy, Joseph I. Shapiro & Zeid J. Khitan. (2017) Systematic review of nephrotoxicity of drugs of abuse, 2005–2016. BMC Nephrology 18:1.
Crossref
Crossref
Joseph J. PalamarMonica J. Barratt, Leigh ConeySilvia S. Martins. (2017) Synthetic Cannabinoid Use Among High School Seniors. Pediatrics 140:4.
Crossref
Crossref
Rosheen Mary Grady, Vladimir Belostotsky, Kristen M Hallett & Christina N Grant. (2017) A 15-year-old boy with acute onset abdominal pain and hypertension. Paediatrics & Child Health 22:6, pages 301-302.
Crossref
Crossref
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Katherine E. Warren, Shirli Tay & Leana S. Wen. (2017) The Role of Public Health in Combatting Synthetic Cannabinoid Use in Adolescents. Journal of Adolescent Health 60:5, pages 483-486.
Crossref
Crossref
Rose Cairns, Jared A. Brown, Naren Gunja & Nicholas A. Buckley. (2017) The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre. International Journal of Drug Policy 43, pages 74-82.
Crossref
Crossref
Andrew L. NinnemannHye Jeong ChoiGregory L. Stuart & Jeff R. Temple. (2017) Longitudinal Predictors of Synthetic Cannabinoid Use in Adolescents. Pediatrics 139:4.
Crossref
Crossref
Axel J. Adams, Samuel D. Banister, Lisandro Irizarry, Jordan Trecki, Michael Schwartz & Roy Gerona. (2017) ?Zombie? Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York. New England Journal of Medicine 376:3, pages 235-242.
Crossref
Crossref
Colin Davidson, Jolanta Opacka-Juffry, Angel Arevalo-Martin, Daniel Garcia-Ovejero, Eduardo Molina-Holgado & Francisco Molina-Holgado. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
135
168
.
D. French. 2017.
153
198
.
A. Helander. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
839
847
.
R. Abalo & M. Isabel Martín-Fontelles. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
439
449
.
Joshua D. King. 2017. Critical Care Toxicology. Critical Care Toxicology
409
423
.
Andrew A. Monte. 2017. Critical Care Toxicology. Critical Care Toxicology
1609
1616
.
Austin Adair, Spencer C. Greene, Christopher S. Greeley, Ryan D. Coleman & Lara S. Shekerdemian. (2016) Synthetic Cannabinoid Exposure. Clinical Pediatrics 55:11, pages 1075-1077.
Crossref
Crossref
Garrett Greenan, Sarwat B. Ahmad, Megan G. Anders, Alexia Leeser, Jonathan S. Bromberg & Silke V. Niederhaus. (2016) Recreational marijuana use is not associated with worse outcomes after renal transplantation. Clinical Transplantation 30:10, pages 1340-1346.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Current Practice in Forensic Medicine. Current Practice in Forensic Medicine
35
46
.
Line Marie Nielsen, Niels Bjerre Holm, Lars Olsen & Kristian Linnet. (2016) Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11. Drug Testing and Analysis 8:8, pages 792-800.
Crossref
Crossref
Simon Elliott. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
94
126
.
Mathias Fietzke, Andreas Thomas, Justus Beike, Marcus Alexander Rothschild, Mario Thevis & Katja Mercer-Chalmers-Bender. (2016) In vitro elucidation of the metabolic profile of the synthetic cannabinoid receptor agonists JWH-175 and JWH-176. Forensic Toxicology 34:2, pages 353-362.
Crossref
Crossref
Abdulaziz A. Aldlgan & Hazel J. Torrance.. (2016) Bioanalytical methods for the determination of synthetic cannabinoids and metabolites in biological specimens. TrAC Trends in Analytical Chemistry 80, pages 444-457.
Crossref
Crossref
Michael B. Gatch & Michael J. Forster. (2016) Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats. Psychopharmacology 233:10, pages 1901-1910.
Crossref
Crossref
Piotr Adamowicz. (2016) Fatal intoxication with synthetic cannabinoid MDMB-CHMICA. Forensic Science International 261, pages e5-e10.
Crossref
Crossref
Liana Fattore. (2016) Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry 79:7, pages 539-548.
Crossref
Crossref
Jacqueline R. Argamany, Kelly R. Reveles & Bryson Duhon. (2016) Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure. The American Journal of Emergency Medicine 34:4, pages 765.e1-765.e2.
Crossref
Crossref
Jean-Pierre Goullé & Michel Guerbet. (2016) Cannabinoïdes de synthèse et nouvelles drogues. Quoi de neuf ?. Revue Francophone des Laboratoires 2016:479, pages 33-42.
Crossref
Crossref
Daniel Castellanos. (2016) Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World Journal of Clinical Pediatrics 5:1, pages 16.
Crossref
Crossref
Joshua D. King. 2016. Critical Care Toxicology. Critical Care Toxicology
1
15
.
Andrew A. Monte. 2016. Critical Care Toxicology. Critical Care Toxicology
1
8
.
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
Ivor S. Douglas, Timothy E. Albertson, Patricia Folan, Nicola A. Hanania, Donald P. Tashkin, Dona J. Upson & Frank T. Leone. (2015) Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. Annals of the American Thoracic Society 12:11, pages 1700-1710.
Crossref
Crossref
Zoltán V VargaPeter Ferdinandy, Lucas Liaudet & Pál Pacher. (2015) Drug-induced mitochondrial dysfunction and cardiotoxicity. American Journal of Physiology-Heart and Circulatory Physiology 309:9, pages H1453-H1467.
Crossref
Crossref
C. Lovett, D. M. Wood & P. I. Dargan. (2015) Pharmacology and toxicology of the synthetic cannabinoid receptor agonistsPharmacologie et toxicologie des agonistes synthétiques des récepteurs cannabinoïdes. Réanimation 24:5, pages 527-541.
Crossref
Crossref
Samuel D. Banister, Jordyn Stuart, Richard C. Kevin, Amelia Edington, Mitchell Longworth, Shane M. Wilkinson, Corinne Beinat, Alexandra S. Buchanan, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor & Michael Kassiou. (2015) Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chemical Neuroscience 6:8, pages 1445-1458.
Crossref
Crossref
Brooke Mills, Andres Yepes & Kenneth Nugent. (2015) Synthetic Cannabinoids. The American Journal of the Medical Sciences 350:1, pages 59-62.
Crossref
Crossref
Donald E. Greydanus, Gabriel Kaplan, Louis E. BaxterSrSr, Dilip R. Patel & Cynthia L. Feucht. (2015) Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?. Disease-a-Month 61:4, pages 118-175.
Crossref
Crossref
R. Geryk, M. Švidrnoch, A. Přibylka, K. Kalíková, V. Maier & E. Tesařová. (2015) A supercritical fluid chromatography method for the systematic toxicology analysis of cannabinoids and their metabolites. Analytical Methods 7:15, pages 6056-6059.
Crossref
Crossref
Ashakumary Lakshmikuttyamma & Abigail Kay. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
45
56
.